跳转至内容
Merck

[Necrotizing gastritis in a patient in severe neutropenia].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (2015-02-27)
Konrad Pielaciński, Ewa Lech-Marańda, Krzysztof Warzocha, Marek Dedecjus, Monika Prochorec-Sobieszek, Andrzej B Szczepanik
摘要

One extremely rare complication of chemotherapy for hematologic malignancies that is burdened with a high mortality rate (50%-80%) is necrotizing gastritis and gastric gangrene as result of poor clinical outcome of neutropenic gastritis (NG). We present a unique case of a neutropenic patient with necrotizing full thickness gastritis due to bacterial and fungal infection. Up to date only few such cases have been reported in world literature. A 28-year-old patient was subjected to dose-escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone), (chemotherapy regimen) for Hodgkin lymphoma. In neutropenic patient abdominal pain, bleeding from the alimentary tract was observed. Hemorrhagic gastritis was recognized at endoscopy and CT demonstrated marked gastric wall thickness. Following NG diagnosis intensive treatment was initiated. On day 2 the patient's condition deteriorated (septic shock, multiple organ failure). Repeat endoscopy revealed gastric necrosis and laparotomy was performed. As consequence of cardiac arrest and cardiopulmonary resuscitation the surgical procedure was limited to total gastrectomy, feeding jejustomy and esophageal drainage through nasoesophageal catherization. Roux-loop esophagojejunostomy was performed on day 22 and supplemented 4 days later by endoscopic placement of covered self-expandable stent due to anastomosis leak. The procedure proved successful and oral feeding was well-tolerated. The patient was discharged in 32 days following recognition of gastric necrosis. Chemotherapy complications in neutropenic patients are life-threatening conditions. Immediate pharmacological treatment usually leads to improvement. Surgical management usually the resection of necrotic zones is restricted to cases of poor prognosis or deterioration of patient's condition and complications.

材料
货号
品牌
产品描述

Sigma-Aldrich
阿霉素 盐酸盐, 98.0-102.0% (HPLC)
Sigma-Aldrich
依托泊苷, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
阿霉素 盐酸盐, suitable for fluorescence, 98.0-102.0% (HPLC)
USP
强的松, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
硫酸博来霉素 来源于轮枝链霉菌, crystalline, 1.5-2.0 U/mg
Sigma-Aldrich
强的松, ≥98%
Sigma-Aldrich
硫酸博来霉素 来源于轮枝链霉菌, BioXtra, crystalline
Sigma-Aldrich
硫酸博来霉素 来源于轮枝链霉菌, 1.5-2.0 units/mg solid, BioReagent, suitable for cell culture
Sigma-Aldrich
长春新碱 硫酸盐, 95.0-105.0% (HPLC), powder or crystals
USP
阿霉素 盐酸盐, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
硫酸博来霉素 来源于轮枝链霉菌, for fluorescence, mixture of bleomycin sulfate salts, lyophilized, powder or crystals, white to off-white
Sigma-Aldrich
Procarbazine hydrochloride, ≥98% (HPLC)
阿霉素 盐酸盐, European Pharmacopoeia (EP) Reference Standard
Supelco
强的松, Pharmaceutical Secondary Standard; Certified Reference Material
硫酸博来霉素, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
长春新碱 硫酸酯, meets USP testing specifications
依托泊苷, European Pharmacopoeia (EP) Reference Standard
硫酸长春新碱, European Pharmacopoeia (EP) Reference Standard
依托泊苷, European Pharmacopoeia (EP) Reference Standard